SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY 433.91-4.9%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (96)12/12/2006 9:27:31 AM
From: tuck  Read Replies (1) of 166
 
>>Alnylam Announces Public Offering of 4,700,000 Shares of Common Stock
Monday December 11, 4:36 pm ET

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News) announced today its intention to offer and sell approximately 4,700,000 shares of common stock in a public offering.

The offering is underwritten by Banc of America Securities LLC. Alnylam also intends to grant the underwriter a thirty-day option to purchase up to approximately 705,000 additional shares.<<

Wise move to take advantage of the run-up. This will also give me the opportunity to cover with a bit of profit.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext